pantoprazole has been researched along with Low Bone Density in 4 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with pantoprazole did not have any bone protective or deleterious effects." | 1.46 | Pantoprazole, a proton pump inhibitor, does not prevent botulinum toxin induced disuse osteopenia in mice. ( Brüel, A; Thomsen, JS; Vegger, JB, 2017) |
| "In pantoprazole-treated rats a decreased BMD was detected (0." | 1.43 | Effects of long-term administration of pantoprazole on bone mineral density in young male rats. ( Bolanowski, M; Jędrzejuk, D; Kwiatkowska, J; Landwójtowicz, M; Matuszewska, A; Nowak, B; Pieśniewska, M; Rzeszutko, M; Szandruk, M; Szeląg, A; Zduniak, K, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saki, F | 1 |
| Shams, M | 1 |
| Dastghaib, S | 1 |
| Koohpeyma, F | 1 |
| Vegger, JB | 1 |
| Brüel, A | 1 |
| Thomsen, JS | 1 |
| Matuszewska, A | 1 |
| Nowak, B | 1 |
| Rzeszutko, M | 1 |
| Zduniak, K | 1 |
| Szandruk, M | 1 |
| Jędrzejuk, D | 1 |
| Landwójtowicz, M | 1 |
| Bolanowski, M | 1 |
| Pieśniewska, M | 1 |
| Kwiatkowska, J | 1 |
| Szeląg, A | 1 |
| Pytlik, M | 1 |
| Cegieła, U | 1 |
| Folwarczna, J | 1 |
| Nowińska, B | 1 |
4 other studies available for pantoprazole and Low Bone Density
| Article | Year |
|---|---|
Pantoprazole-Induced Bone Loss through Gastrin Secretion: A Stereological Study.
Topics: Alkaline Phosphatase; Animals; Bone Diseases, Metabolic; Gastrins; Male; Octreotide; Pantoprazole; P | 2023 |
Pantoprazole, a proton pump inhibitor, does not prevent botulinum toxin induced disuse osteopenia in mice.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Bone and Bones; Bone Density; Bone Diseases, Metab | 2017 |
Effects of long-term administration of pantoprazole on bone mineral density in young male rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Bone Density; Bone Diseases, Metabolic; Bone Remod | 2016 |
Proton pump (H+/K+-ATPase) inhibitors weaken the protective effect of alendronate on bone mechanical properties in estrogen-deficient rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Alendronate; Animals; Bone and Bones; Bone Density; Bone De | 2012 |